New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2014
09:24 EDTHTWRHeartWare shares recommended on weakness at Canaccord
Canaccord recommends buying HearWare on any weakness related to the Q4 pre-announcement. The firm said sales growth was strong on an absolute basis but might not have met high Street expectations. Shares are Buy rated with a $115 price target.
News For HTWR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2015
09:52 EDTHTWRThoratec comments on HeartMate II data in ENDURANCE therapy trial
Subscribe for More Information
08:53 EDTHTWRBofA/Merrill medical technology analysts hold analyst/industry conference call
Subscribe for More Information
05:32 EDTHTWRHeartWare achieves primary endpoint in ENDURANCE clinical trial
Subscribe for More Information
April 11, 2015
14:10 EDTHTWRLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
April 10, 2015
08:37 EDTHTWRThoratec price target raised to $50 from $45 at Leerink
Subscribe for More Information
April 9, 2015
07:32 EDTHTWRHeartWare receives Health Canada approval for commercialization of assist system
HeartWare announced that it has received approval from Health Canada, the country's federal department responsible for helping Canadians maintain their health, to market the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.
April 7, 2015
10:48 EDTHTWRLeerink medical supplies & devices analyst has analyst/industry conference call
Subscribe for More Information
April 6, 2015
08:58 EDTHTWRCredit Suisse more optimistic on HeartWare
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use